by medical institutions
worldwide Read More


Compumedics offers innovative and comprehensive computer based diagnostic systems.

Company News

Compumedics latest news.

Investor Relations

Compumedics portal for Investor Relations.

Latest News

Come explore the features of the NEW Profusion neXus 360

View the videos below or visit the product discovery page


About Compumedics

Our Vision is to set the innovative and technological standards in monitoring products for improved health care. We exist to identify and deliver accessible medical technologies to the world. We provide our customers with products of superior technology, ease of use and reliable quality.

Our Values

People: Trust, Respect and Relationships
Ethics: Uncompromising integrity in business conduct
Contribution: to the industry and community

Our Clients


  • 2016 Annual Report Released

    Compumedics is pleased to release the Annual Report for FY2016. > September 2016 Annual Report: Front Section – Click here (PDF) > September 2016 Annual Report : Financial Statements – Click here (PDF)

    Read more

  • Successful Completion of $6.5m Capital Raising

    Compumedics Limited (ASX: CMP) (“Compumedics” and “Company”) – an international leader in medical devices for sleep, brain and ultrasonic blood-flow monitoring – is pleased to announce that it has successfully completed a $6.5m placement, which was announced to market on … Read More

    Read more

  • Trading Halt Request

    Please click below to download >>Trading Halt Request (PDF) >>Trading Halt(PDF)

    Read more

  • August 2016 Roadshow Presentation

    >>Please download the roadshow presentation by clicking here (PDF 1.9MB) About Compumedics Limited Compumedics Limited [ASX: CMP] is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring … Read More

    Read more

  • Business Update: Appendix 4E Release 30 June 2016

    >> DOWNLOAD Appendix 4E 30 Jun 16 FINAL Current Performance Highlights • NPAT up 66% to $3.3m compared to $2.0m for the year ended 30 June 2015. EBITDA up 22% to $5.0m compared to $4.1m for the year ending 30 … Read More

    Read more

Upcoming Events

  • Compumedics Neuroscan School Hamburg (Research)

    Read more

  • Compumedics Neuroscan School Beijing (Research)

    Read more

  • DACH

    Read more

  • Sleep DownUnder 2016

    Read more

  • Compumedics Neuroscan School, Sydney

    Compumedics is please to present our next Neuroscan school featuring the CURRY software in Sydney, Australia. We will also be previewing the latest version CURRY8 at this event. For further information, please download the PDF

    Read more